CORZ
A little insider appetite
Core Scientific’s director Elizabeth Crain bought 6,000 shares, a purchase worth about $110,000. That’s not exactly yacht money, but it is the kind of move investors watch closely because insiders usually know the business better than the rest of us doomscrolling from the sidelines.
Why you should care
Insider buys don’t guarantee anything, of course. But when a director is adding to the pile, it can hint that the board thinks the stock is undervalued or that the company’s setup still looks attractive after the recent noise around crypto and data-center demand.
The tiny contradiction problem
The headline says buy, while the key point says the transaction was valued at approximately $110,000. Either way, the message is the same: a Core Scientific insider just put real skin in the game.
Big picture: investors often treat insider buying like a CEO-level wink. It’s not a prophecy, but it’s usually not nothing either.